XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF LOSS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Operating expenses:        
Research and development expenses $ 4,541 $ 6,762 $ 11,532 $ 10,614
Selling, general and administrative expenses 21,804 15,174 43,439 26,186
Restructuring expense (income) 3,592 0 3,592 (53)
Total operating expense 29,937 21,936 58,563 36,747
Operating loss (29,937) (21,936) (58,563) (36,747)
Investment and other income, net 192 432 55 1,042
Interest expense (3,506) (1,930) (5,523) (3,859)
Gain from release of certain liabilities 0 88 33 166
Loss before income taxes (33,251) (23,346) (63,998) (39,398)
Income tax provision (benefit) 30,193 (3,765) 25,870 (6,372)
Net loss $ (63,444) $ (19,581) $ (89,868) $ (33,026)
Net loss per share - basic (in dollars per share) $ (1.07) $ (0.33) $ (1.52) $ (0.56)
Net loss per share - diluted (in dollars per share) $ (1.07) $ (0.33) $ (1.52) $ (0.56)
Weighted average number of shares outstanding - basic (in shares) 59,037 58,488 58,931 58,465
Weighted average number of shares outstanding - diluted (in shares) 59,037 58,488 58,931 58,465